Market Overview

Akorn Shares Rally Following Increased Price Target

Related AKRX
Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Benzinga's Volume Movers
Merck Sells Japan Eye-Treatment Rights (Fox Business)

Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.

The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.

Shares are currently up 5.25 percent at $34.99.

Posted-In: NeedhamAnalyst Color News Price Target Analyst Ratings

 

Most Popular

Related Articles (AKRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free